Clinical Trials Browser

Borderline Resectable Pancreatic Cancer

Stomach Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Neoplasm Metastasis

Stomach Neoplasms

Rectal Neoplasms

Digestive System Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Colorectal Cancer Metastatic

Carcinoma, Hepatocellular

Locally Advanced Unresectable Gastric Adenocarcinoma

Colorectal Cancer Metastatic

Stomach Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Biliary Tract Carcinoma

Carcinoma, Hepatocellular

Stomach Neoplasms

Biliary Tract Adenocarcinoma

Locally Advanced Gastric Cancer

Neoplasm Metastasis, Pancreatic Neoplasms

Carcinoma, Hepatocellular

Rectal Neoplasms

Cholangiocarcinoma

Stomach Neoplasms

Stomach Neoplasms

HER2-positive

Biliary Tract Tumor

Stomach Neoplasms

Neoplasms by Histologic Type, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Extranodal NK-T-Cell

Stomach Neoplasms

Pancreatic Cancer Non-resectable

Bile Duct Neoplasms, Cholangiocarcinoma

Advanced Colorectal Cancer

High-risk Locally Advanced Colorectal Cancer

Carcinoma, Hepatocellular

Colonic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Clinical Trials

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

IMAGINE

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

NIVOFGFR2

LARCT-US

ALTER-G-001

LOTS

AIO-KRK-0116

RAIC

POCHI

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery

Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer

HIPEC

FIND

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

FOOTPATH

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer

Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

IRIGA